Results 81 to 90 of about 30,706 (198)

Detection and Quantification of Glucuronidation of Ursolic Acid (UA) in Human Liver Microsomes (HLMs). [PDF]

, 2018
https://scholarscompass.vcu.edu/uresposters/1270/thumbnail ...
Gerk, Philip M., Tolliboeva, Kamola
core   +1 more source

Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ - [PDF]

, 2014
Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious side effect of bisphosphonate (BP)-based treatments. This retrospective study aimed to investigate the risk factors and predictive markers in cases where
Kaneuji, Takeshi, Kataoka, Yoshihiro, Kiyomiya, Hiroyasu, Mitsugi, Sho, Miyamoto, Ikuya, Nakamichi, Ikuo, Nogami, Shinnosuke, Sakurai, Takuma, Takahashi, Tetsu, Tanaka, K., Yamamoto, Noriaki, Yamashita, Yoshihiro, Yamauchi, Kensuke, Yoshiga, Daigo   +13 more
core   +1 more source

Cytochrome P450 enzyme mediated herbal drug interactions (Part 2) [PDF]

, 2014
To date, a number of significant herbal drug interactions have their origins in the alteration of cytochrome P450 (CYP) activity by various phytochemicals. Among the most noteworthy are those involving St.
Phopin, Kamonrat, Prachayasittikul, Virapong, Wanwimolruk, Sompon   +2 more
core  

SIOPE and ESOP recommendations for extemporaneous compounding of oral liquid medicine formulations in paediatric oncology

EJC Paediatric Oncology
Introduction: Scarcity of age appropriate formulations for orally administered medicines for paediatric malignancies is a critical and ongoing issue which necessitates urgent solutions. According to JARC Survey 27 % of oral medicines were never available
Marko Otsokolhich, Maxime Annereau, Tiene Bauters, Laszlo Horvath, Chahinez Nehal, Sherif Kamal, Gilles Vassal, Svetlana Buraja   +7 more
doaj   +1 more source

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study. [PDF]

, 2017
BackgroundCabozantinib, an orally bioavailable inhibitor of tyrosine kinases including MET, AXL, and VEGF receptors, was assessed in patients with hepatocellular carcinoma (HCC) as part of a phase 2 randomized discontinuation trial with nine tumor-type ...
Braiteh, F, Burris, H, Cohn, AL, Foster, P, Kelley, RK, Lee, Y, Spira, A, Su, W-C, Van Cutsem, E, Verslype, C, Vogelzang, N, Yang, T-S   +11 more
core  

Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach

Frontiers in Chemistry
Introduction: Cancer is the second most prevalent cause of mortality in the world, despite the availability of several medications for cancer treatment.
Farhan Siddique, Farhan Siddique, Ahmar Anwaar, Maryam Bashir, Maryam Bashir, Sumaira Nadeem, Ravi Rawat, Volkan Eyupoglu, Samina Afzal, Mehvish Bibi, Yousef A. Bin Jardan, Mohammed Bourhia   +11 more
doaj   +1 more source

Effects of three oral analgesics on postoperative pain following root canal preparation: a controlled clinical trial [PDF]

, 2012
Aim  To compare the effects of single doses of three oral medications on postoperative pain following instrumentation of root canals in teeth with irreversible pulpitis.
Albashaireh, Breivik, Collins, Dayer, Dionne, Dionne, Doroschak, Georgopoulou, Glennon, Gottesdiener, Haas, Holstein, Imura, Jung, Keiser, Madison, McNicholas, McVerry, Menhinick, Morse, Morse, Nakanishi, Ng, O’Keefe, Penniston, Rosenberg, Roszkowski, Sathorn, Schnitzer, Siqueira, Thun, Torabinejad, Trope, Whitten, Wideman, Wright   +35 more
core   +1 more source

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K., Anderson, J., Andrews, S., Arrindell, D., Ballesteros, J., Bingham, C. O., Boyer, J., Brogdon, C., Chen, D., Chonzi, D., Cotarla, I., Cunha, R., Dadu, R., Davies, M., Dawson, M., Diab, A., Dicker, Adam, Eifler, L., Ernstoff, M. S., Ferguson, A., Ferlini, C., Frankel, S., Go, W., Gochett, C., Goldberg, J., Goncalves, P., Goswami, T., Gregory, N., Gulley, J. L., Hamad, L., Hayreh, V., Helie, N., Holmes, W., Hsu, J. Y., Ibrahim, R., Kaufman, H. L., Kim, S., Lacouture, M. E., Lambotte, O., Larocca, C., LeBoeuf, N. R., Lehman, K., Lenihan, D., Ley-Acosta, S., Luke, J., McClure, J., Michelon, E., Nakamura, M., Onofrei, C., Patel, K., Piperdi, B., Puzanov, I., Rasheed, Z., Reshef, D., Riemer, J., Robert, C., Sarkeshik, M., Saylors, A., Schreiber, J., Shafer-Weaver, K., Shannon, V., Sharfman, W., Sharma, R., Sharon, E., Sherry, R., Silk, A. W., Simonson, C., Skondra, D., Suarez-Almazor, M. E., Thomas, C., Thompson, J. A., Trehu, E., Tresnan, D., Turner, M., Wang, Y., Wariabharaj, D., Waxman, I., Wiley, K., Wood, L., Zhang, L., Zheng, P.   +80 more
core   +2 more sources

Perspectives on Drug Product Design Among Patients with Lung Cancer in the United Kingdom

Pulmonary Therapy
Introduction The use of oral anticancer medications has become more prevalent in cancer therapy. This is particularly the case in the management of advanced non-small cell lung cancer (NSCLC).
Joshua R. Coulter, Louis Edward Baig, Amy Antipas, Debra Montague, Angela Terry, Sally-Anne Dews, Michaela Ogden-Barker, Colm Doody, Brett Hauber   +8 more
doaj   +1 more source

The palliative-supportive care unit in a comprehensive cancer center as crossroad for patients' oncological pathway [PDF]

, 2016
Aim The aim of this study was to assess how an admission to an acute palliative-supportive care unit (APSCU), may influence the therapeutic trajectory of advanced cancer patients.
Adile, C., Caruselli, A., CASUCCIO, Alessandra, Costanzi, A., Ferrera, P., Marchetti, P., Mercadante, S.   +6 more
core   +2 more sources